Date: October 30, 2026
Regulatory Disclosure Context
Paras Healthcare Limited has received and forwarded a mandatory disclosure from acquirer entities under Regulation 29(1) of the SEBI SAST Regulations. The disclosure pertains to shareholding changes following the company's recent IPO.
Shareholding Disclosure Details
Acquirer Entities:
- 360 ONE Special Opportunities Fund – Series 9
- 360 ONE Special Opportunities Fund – Series 10
- 360 ONE Special Opportunities Fund – Series 11
- 360 ONE Special Opportunities Fund – Series 12
- 360 ONE Special Opportunities Fund – Series 13
- 360 ONE Private Equity Fund- Series 2
- 360 ONE Equity Opportunity Fund- Series 4
Shareholding Position:
- Total shares held: 78,81,992 equity shares
- Percentage of total share capital: 7.28%
- Percentage of total diluted share capital: 7.28%
Transaction Details:
- Mode of acquisition: Conversion of unlisted shares into listed shares on account of an IPO
- Date of acquisition: October 28, 2026 (listing date)
- No actual change in number of shares held - only change in status from unlisted to listed
- No shares are pledged or encumbered
- No warrants or convertible securities held
Capital Structure Reference:
- Equity share capital before acquisition: 10,82,01,194 shares (as per shareholder pattern on October 27, 2026)
- Equity share capital after acquisition: 10,82,01,194 shares (unchanged)
- Total diluted share capital: 10,85,00,790 shares (as per shareholder pattern on October 27, 2026)
Regulatory Status:
- The acquirer does not belong to the Promoter/Promoter group of Paras Healthcare Limited
- Disclosure made to both BSE Limited and NSE Limited where company shares are listed
Signatories and Compliance Officers
From Paras Healthcare Limited:
- Rahul Kumar, Company Secretary and Compliance Officer (ICSI Membership No.: A20928)
From Acquirer Entities:
- Vijay Shah, Compliance Officer - 360 ONE Alternates Asset Management Limited (Investment Manager)
- Sonali Tendulkar, Compliance Officer - 360 ONE Asset Management Limited (Investment Manager)
Additional Information
- The disclosure will be hosted on the company's website at https://www.parashospitals.com/investors
- The disclosure was made within the mandatory two working days timeframe as required under Regulation 29(3) of SEBI SAST Regulations